COVID-19 high-risk groups: Why the immune system is less effective at fighting the virus

by Charité - Universitätsmedizin BerlinThe older a person with COVID-19 is, the higher the frequency of T-helper cells which react to the virus. However, fewer and fewer of these cells produce th

Updated on: April 10,2024

COVID-19 high-risk groups: Why the immune system is less effective at fighting the virus

by Charité - Universitätsmedizin BerlinThe older a person with COVID-19 is, the higher the frequency of T-helper cells which react to the virus. However, fewer and fewer of these cells produce th

Updated on:April 10,2024

WHO unveils plan to end African mpox outbreak

by Robin FosterAs an mpox outbreak continues to rage in Africa, the World Health Organization on Monday launched a six-month plan to quell its spread."Thempoxoutbreaks in the Democrat

Updated on: September 10,2024

WHO unveils plan to end African mpox outbreak

by Robin FosterAs an mpox outbreak continues to rage in Africa, the World Health Organization on Monday launched a six-month plan to quell its spread."Thempoxoutbreaks in the Democrat

Updated on:September 10,2024

Why has October been so bad for a virus known as RSV?

by Harriet Blair RowanCredit: Pixabay/CC0 Public DomainOctober is usually a quiet month for Dr. Julie Kim and her colleagues at their pediatrics practice in Los Gatos, after the summer rush for physic

Updated on: June 08,2024

Why has October been so bad for a virus known as RSV?

by Harriet Blair RowanCredit: Pixabay/CC0 Public DomainOctober is usually a quiet month for Dr. Julie Kim and her colleagues at their pediatrics practice in Los Gatos, after the summer rush for physic

Updated on:June 08,2024

SARS-CoV-2: Alert immune system in the respiratory tract protects children from severe courses of the disease

by German Cancer Research CenterSynopsis SARS-CoV-2 infection is milder in children, but the underlying mechanisms are not fully understood. This study finds increased interactions between immune

Updated on: April 22,2024

SARS-CoV-2: Alert immune system in the respiratory tract protects children from severe courses of the disease

by German Cancer Research CenterSynopsis SARS-CoV-2 infection is milder in children, but the underlying mechanisms are not fully understood. This study finds increased interactions between immune

Updated on:April 22,2024

How HIV research has reshaped modern medicine

If it wasn’t for the decades of HIV research, we would not have had the COVID-19 vaccines so rapidly.

Updated on: November 28,2024

How HIV research has reshaped modern medicine

If it wasn’t for the decades of HIV research, we would not have had the COVID-19 vaccines so rapidly.

Updated on:November 28,2024

Bartonella and Babesia co-infection detected in patients with chronic illness

by Tracey Peake,North Carolina State UniversityPhotographs taken by the parents of a rapid onset, homogeneous, non-pruritic red rash on the upper left arm (arrows) in a 2.5-year-old girl (study

Updated on: July 19,2024

Bartonella and Babesia co-infection detected in patients with chronic illness

by Tracey Peake,North Carolina State UniversityPhotographs taken by the parents of a rapid onset, homogeneous, non-pruritic red rash on the upper left arm (arrows) in a 2.5-year-old girl (study

Updated on:July 19,2024

T-cell abnormalities in severe COVID-19 cases

by Kumamoto UniversityA major difference between mild and severe cases of COVID-19 may be the extreme activation of T cells as they react to the virus. In mild cases, T cell activation is slowed

Updated on: April 12,2024

T-cell abnormalities in severe COVID-19 cases

by Kumamoto UniversityA major difference between mild and severe cases of COVID-19 may be the extreme activation of T cells as they react to the virus. In mild cases, T cell activation is slowed

Updated on:April 12,2024

Chlamydia vaccine shows promise in early trial

by Robin FosterA chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI).There is curre

Updated on: April 30,2024

Chlamydia vaccine shows promise in early trial

by Robin FosterA chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI).There is curre

Updated on:April 30,2024

Mutations do not predict the severity of current variants of SARS-CoV-2, finds study

byUniversity of North Carolina at CharlotteThe fragment antigen-binding region of the neutralizing antibody CV2.1169, shown on the left in red, in complex with the receptor binding domain of the

Updated on: April 30,2024

Mutations do not predict the severity of current variants of SARS-CoV-2, finds study

byUniversity of North Carolina at CharlotteThe fragment antigen-binding region of the neutralizing antibody CV2.1169, shown on the left in red, in complex with the receptor binding domain of the

Updated on:April 30,2024

Experimental therapeutic reduces advanced-stage influenza viral loads faster than current therapies in preclinical study

by Steve Martin,Purdue UniversityAn Eradivir employee conducts research on the company's EV25 influenza therapeutic. Research published inProceedings of the National Academy of Science

Updated on: November 29,2024

Experimental therapeutic reduces advanced-stage influenza viral loads faster than current therapies in preclinical study

by Steve Martin,Purdue UniversityAn Eradivir employee conducts research on the company's EV25 influenza therapeutic. Research published inProceedings of the National Academy of Science

Updated on:November 29,2024

COVID-19 vaccine elicits weak antibody response in people taking immunosuppressant

by Washington University School of MedicineCredit: Pixabay/CC0 Public DomainPeople who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors—a class of immunosuppressants used

Updated on: April 12,2024

COVID-19 vaccine elicits weak antibody response in people taking immunosuppressant

by Washington University School of MedicineCredit: Pixabay/CC0 Public DomainPeople who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors—a class of immunosuppressants used

Updated on:April 12,2024

Gilead licenses HIV-prevention drug to generic drugmakers

Credit: Pixabay/CC0 Public DomainUS pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income

Updated on: October 21,2024

Gilead licenses HIV-prevention drug to generic drugmakers

Credit: Pixabay/CC0 Public DomainUS pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income

Updated on:October 21,2024